GX EJ7 Pill: gray, four-sided, 17mm
Generic Name: lamivudine
The pill with imprint GX EJ7 (Gray, Four-sided, 17mm) has been identified as Epivir 300 mg and is used for Hepatitis B, Nonoccupational Exposure, Occupational Exposure, and HIV Infection. It belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is not a controlled substance.
Images for GX EJ7
Epivir
- Generic Name
- lamivudine
- Imprint
- GX EJ7
- Strength
- 300 mg
- Color
- Gray
- Size
- 17.00 mm
- Shape
- Four-sided
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- GlaxoSmithKline
- National Drug Code (NDC)
- 00173-0714 (Discontinued)
- Inactive Ingredients
-
ferrosoferric oxide,
hypromelloses,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol,
polysorbate 80,
sodium starch glycolate type A potato,
titanium dioxide
Note: Inactive ingredients may vary.
See also:
More about Epivir (lamivudine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
- En español
Patient resources
Professional resources
Other formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.